Alberico L Catapano

Summary

Affiliation: University of Milan
Country: Italy

Publications

  1. ncbi Combination therapy in cholesterol reduction: focus on ezetimibe and statins
    Liliana Grigore
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Vasc Health Risk Manag 4:267-78. 2008
  2. ncbi Global cardiovascular risk : the role of plasma lipids
    Alberico L Catapano
    Department of Pharmacological Sciences, Director Center for the Study of Atherosclerosis, Marie Curie Training Centre for Cardiovascular Diseases, University of Milan, Via G Balzaretti 9 20133, Milan, Italy
    High Blood Press Cardiovasc Prev 12:125-33. 2005
  3. ncbi Statin-induced myotoxicity: pharmacokinetic differences among statins and the risk of rhabdomyolysis, with particular reference to pitavastatin
    Alberico L Catapano
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Curr Vasc Pharmacol 10:257-67. 2012
  4. ncbi Averting a pandemic health crisis in Europe by 2020: what physicians need to know regarding cholesterol management
    Alberico L Catapano
    Centre for the Study of Atherosclerosis, Marie Curie Training Centre for Cardiovascular Diseases, University of Milan, Milan, Italy
    Eur J Cardiovasc Prev Rehabil 14:340-5. 2007
  5. ncbi Perspectives on low-density lipoprotein cholesterol goal achievement
    Alberico L Catapano
    Marie Curie Training Centre for Cardiovascular Diseases, University of Milan, Milan, Italy
    Curr Med Res Opin 25:431-47. 2009
  6. ncbi Native LDL and oxidized LDL modulate cyclooxygenase-2 expression in HUVECs through a p38-MAPK, NF-kappaB, CRE dependent pathway and affect PGE2 synthesis
    G D Norata
    Department of Pharmacological Sciences, University of Milan, Italy
    Int J Mol Med 14:353-9. 2004
  7. ncbi Low density lipoprotein oxidation, antioxidants, and atherosclerosis
    A L Catapano
    Institute of Pharmacological Sciences, University of Milan, Italy
    Curr Opin Cardiol 15:355-63. 2000
  8. ncbi Pitavastatin - pharmacological profile from early phase studies
    Alberico L Catapano
    Centre for the Study of Atherosclerosis, Department of Pharmacological Sciences, University of Milan, and IRCSS Multimedica, Sesto S Giovanni, Milan, Italy
    Atheroscler Suppl 11:3-7. 2010
  9. ncbi [Intestinal cholesterol absorption: a pharmacological target for lowering of plasma cholesterol]
    Alberico L Catapano
    Dipartimento di Scienze Farmacologiche, Centro per lo Studio dell Aterosclerosi, Universita degli Studi, Milano
    Ital Heart J Suppl 5:779-84. 2004
  10. ncbi Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients
    Alberico L Catapano
    University of Milan, Milan, Italy
    Curr Med Res Opin 22:2041-53. 2006

Collaborators

Detail Information

Publications54

  1. ncbi Combination therapy in cholesterol reduction: focus on ezetimibe and statins
    Liliana Grigore
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Vasc Health Risk Manag 4:267-78. 2008
    ....
  2. ncbi Global cardiovascular risk : the role of plasma lipids
    Alberico L Catapano
    Department of Pharmacological Sciences, Director Center for the Study of Atherosclerosis, Marie Curie Training Centre for Cardiovascular Diseases, University of Milan, Via G Balzaretti 9 20133, Milan, Italy
    High Blood Press Cardiovasc Prev 12:125-33. 2005
    ..g. patients with previous myocardial infarction or stroke)...
  3. ncbi Statin-induced myotoxicity: pharmacokinetic differences among statins and the risk of rhabdomyolysis, with particular reference to pitavastatin
    Alberico L Catapano
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Curr Vasc Pharmacol 10:257-67. 2012
    ..Such differences in drug � drug interaction profiles among available statins offer the possibility of reducing the risk of myotoxicity among high-risk patients...
  4. ncbi Averting a pandemic health crisis in Europe by 2020: what physicians need to know regarding cholesterol management
    Alberico L Catapano
    Centre for the Study of Atherosclerosis, Marie Curie Training Centre for Cardiovascular Diseases, University of Milan, Milan, Italy
    Eur J Cardiovasc Prev Rehabil 14:340-5. 2007
    ..According to a recent report by the Stockholm Network (an independent European 'think tank'), major political, economic, social, and medical changes are urgently needed with respect to cholesterol management to help prevent CVD...
  5. ncbi Perspectives on low-density lipoprotein cholesterol goal achievement
    Alberico L Catapano
    Marie Curie Training Centre for Cardiovascular Diseases, University of Milan, Milan, Italy
    Curr Med Res Opin 25:431-47. 2009
    ..European and US guidelines now recommend lower LDL-C levels, particularly in high-risk patients. Although LDL-C treatment goals to reduce the risk of CHD are clear, many patients do not reach their LDL-C goals...
  6. ncbi Native LDL and oxidized LDL modulate cyclooxygenase-2 expression in HUVECs through a p38-MAPK, NF-kappaB, CRE dependent pathway and affect PGE2 synthesis
    G D Norata
    Department of Pharmacological Sciences, University of Milan, Italy
    Int J Mol Med 14:353-9. 2004
    ....
  7. ncbi Low density lipoprotein oxidation, antioxidants, and atherosclerosis
    A L Catapano
    Institute of Pharmacological Sciences, University of Milan, Italy
    Curr Opin Cardiol 15:355-63. 2000
    ..When it becomes possible to monitor the efficacy of any antioxidant therapy with validated markers of oxidation, the potential influence of vitamins and antioxidants on coronary artery disease will eventually be resolved...
  8. ncbi Pitavastatin - pharmacological profile from early phase studies
    Alberico L Catapano
    Centre for the Study of Atherosclerosis, Department of Pharmacological Sciences, University of Milan, and IRCSS Multimedica, Sesto S Giovanni, Milan, Italy
    Atheroscler Suppl 11:3-7. 2010
    ..Consequently, pitavastatin has minimal drug-food and drug-drug interactions making it a treatment option in the large group of dyslipidaemic people that require multidrug therapy...
  9. ncbi [Intestinal cholesterol absorption: a pharmacological target for lowering of plasma cholesterol]
    Alberico L Catapano
    Dipartimento di Scienze Farmacologiche, Centro per lo Studio dell Aterosclerosi, Universita degli Studi, Milano
    Ital Heart J Suppl 5:779-84. 2004
    ....
  10. ncbi Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients
    Alberico L Catapano
    University of Milan, Milan, Italy
    Curr Med Res Opin 22:2041-53. 2006
    ..To assess the lipid-altering efficacy and safety of ezetimibe/simvastatin single tablet product compared with rosuvastatin at the approved usual starting, next highest, and maximum doses...
  11. ncbi The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance
    Alberico L Catapano
    Center for the Study of Atherosclerosis and Laboratory of Lipoprotein Metabolism, Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Fundam Clin Pharmacol 21:21-6. 2007
    ....
  12. ncbi Oxidized-HDL3 modulates the expression of Cox-2 in human endothelial cells
    Elisa Callegari
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Int J Mol Med 18:209-13. 2006
    ..These data suggest that Ox-HDL induce Cox-2 expression in endothelial cells through a PI3K/NF-IL6-dependent pathway...
  13. ncbi [Rosuvastatin: pharmacologic features]
    Franco Bernini
    Dipartimento di Scienze Farmacologiche, Biologiche e Chimiche Applicate, Universita degli Studi, Campus Universiario, 43100 Parma
    Ital Heart J 4:22S-32S. 2003
    ..Rosuvastatin effectively decreases triglycerides, triglyceride-rich lipoproteins, non-HDL cholesterol, and increases HDL cholesterol. All together these properties will favor the achievement of therapeutic goals in the treated patients...
  14. ncbi Oxidised-HDL3 induces the expression of PAI-1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilization
    Giuseppe D Norata
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Br J Haematol 127:97-104. 2004
    ..In summary, Ox-HDL3 induced PAI-1 mRNA expression and antigen release through a molecular mechanism involving MAPK activation and mRNA stabilization. Thus, oxidative modification converts HDL to a prothrombotic lipoprotein species...
  15. ncbi Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux
    Angela Pirillo
    Department of Pharmacological Sciences, Via Balzaretti, 9, 20133 Milano, Italy
    Cardiovasc Res 75:566-74. 2007
    ..In the present study we investigated the effect of a mild oxidation of HDL(3) on its function as cholesterol acceptor...
  16. ncbi Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases
    Giovanni Corrao
    Department of Statistics, Unit of Biostatistics and Epidemiology, University of Milano Bicocca, Milan, Italy
    Atherosclerosis 217:479-85. 2011
    ..To estimate the cost-effectiveness of enhancing adherence to statin therapy across a large population without signs of pre-existing cardiovascular disease...
  17. ncbi High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells
    Giuseppe D Norata
    Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133, Milan, Italy
    Circulation 111:2805-11. 2005
    ..In addition to its role in reverse cholesterol transport, HDL influences different functions of endothelial cells. In the present study, we investigated in endothelial cells the genes involved in inflammation modulated by HDL...
  18. ncbi C-reactive protein distribution and correlation with traditional cardiovascular risk factors in the Italian population
    Manuela Casula
    Epidemiology and Preventive Pharmacology Centre SEFAP, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milano, Italy
    Eur J Intern Med 24:161-6. 2013
    ..We report the distribution of plasma levels of CRP and its possible relationship with other cardiovascular risk factors in an Italian cohort...
  19. ncbi Reaching LDL-c targets in high-risk patients requires high-efficacy cholesterol-lowering drugs in more than 50% of cases. The results of the CHECK study
    Andrea Poli
    SEFAP, University of Milan, Milan, Italy
    Pharmacol Res 64:393-6. 2011
    ..Our data might conceivably be applied to other low-cardiovascular risk countries and should be taken into account when defining the proportion of drugs with different efficacy and cost in the everyday clinical practice...
  20. ncbi Endothelin-1 does not impair insulin-induced angiogenesis in vitro
    Fabio Pellegatta
    Laboratory of Lipid Metabolism, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, I 20132 Milan, Italy
    Int J Mol Med 28:443-8. 2011
    ..In the two in vitro models of angiogenesis, ET-1 did not inhibit insulin-induced angiogenesis. From these data we conclude that in vitro, at the times and at the concentrations examined, ET-1 does not impair insulin-induced angiogenesis...
  21. ncbi Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia
    Liliana Grigore
    Center for the Study of Atherosclerosis SISA Lombardia, Bassini Hospital, Via Gorki 50, 20092, Cinisello Balsamo, Milan, Italy
    Eur J Clin Pharmacol 69:341-6. 2013
    ....
  22. ncbi Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells
    Angela Pirillo
    Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy
    Atherosclerosis 214:331-7. 2011
    ..Lectin-like oxidized LDL receptor-1 (LOX-1), the endothelial receptor for OxLDL, is believed to be responsible for a number of OxLDL-induced effects in the endothelium...
  23. ncbi Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium
    Giuseppe D Norata
    Department of Pharmacological Sciences, University of Milan, Italy
    Vasc Health Risk Manag 1:119-29. 2005
    ....
  24. ncbi Dual effect of hypochlorite in the modification of high density lipoproteins
    Angela Pirillo
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Biochem Biophys Res Commun 403:447-51. 2010
    ....
  25. ncbi HDLs, immunity, and atherosclerosis
    Giuseppe D Norata
    Department of Pharmacological Sciences, Universita degli Studi di Milano, Centro SISA per lo Studio dell Aterosclerosi, Ospedale Bassini, Cinisello Balsamo, Milan, Italy
    Curr Opin Lipidol 22:410-6. 2011
    ..Among them, the most relevant is the ability of HDL to promote the efflux of excess cholesterol from peripheral tissues to the liver for excretion...
  26. ncbi High-density lipoprotein subfraction 3 decreases ADAMTS-1 expression induced by lipopolysaccharide and tumor necrosis factor-alpha in human endothelial cells
    Giuseppe D Norata
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Matrix Biol 22:557-60. 2004
    ..Since ADAMTS-1 has recently been shown to inhibit endothelial cell proliferation, the result of the present work may represent a new mechanism by which HDL could have a positive effect on endothelial cell and vascular wall function...
  27. ncbi Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration
    Ivano Baragetti
    Department of Internal Medicine, Nephrology and Dialysis Unit, Bassini Hospital, Cinisello Balsamo, Milan, Italy
    Nephrol Dial Transplant 22:3292-7. 2007
    ..In patients with chronic renal failure, the administration of folic acid or its metabolites reduces but does not normalize plasma homocysteine concentrations...
  28. ncbi Plasma resistin levels correlate with determinants of the metabolic syndrome
    G D Norata
    Centro SISA per lo Studio della Aterosclerosi, Ospedale Bassini, Cinisello Balsamo, Milano, Italy
    Eur J Endocrinol 156:279-84. 2007
    ..The aim of the present study was to investigate the relationship of plasma resistin levels with markers of the metabolic syndrome and atherosclerosis in a large population-based study...
  29. ncbi Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status
    G D Norata
    Department of Pharmacological Sciences, University of Milan, Via Balzaretti, 9, 20133 Milan, Italy
    Nutr Metab Cardiovasc Dis 20:56-63. 2010
    ..Adiponectin (ADPN) exerts anti-inflammatory and cardio protective effects and is associated with decreased cardiovascular risk, however its role in patients with chronic kidney disease is unclear...
  30. ncbi Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL
    G D Norata
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Cardiovasc Res 59:169-80. 2003
    ..These findings confirm the involvement of VLDL and Ox-VLDL in endothelial dysfunction and suggest new genes and molecular mechanisms involved in these actions...
  31. ncbi Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction
    G D Norata
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    J Intern Med 262:104-12. 2007
    ..The aim of this study was to investigate the association of the -420C/G polymorphism with metabolic syndrome, obesity, myocardial infarction and kidney disease...
  32. ncbi Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models
    Enrico Ammirati
    Clinical Cardiovascular Biology Centre, San Raffaele Scientific Institute and the Università Vita Salute San Raffaele, Milan, Italy E A, D C, M B Heart Transplantation Division, Ospedale Niguarda Ca Granda, Milan, Italy E A Heart Care Foundation, Florence, Italy E A, A M
    J Am Heart Assoc 1:27-41. 2012
    ..J Am Heart Assoc. 2012;1:27-41.)...
  33. ncbi Monitoring statin safety in primary care
    Elena Tragni
    Epidemiology and Preventive Pharmacology Center, Department of Pharmacological Sciences, University of Milan, Via Balzaretti, Milan, Italy
    Pharmacoepidemiol Drug Saf 16:652-7. 2007
    ..To verify General Practitioners (GPs) compliance to the recommended laboratory monitoring for statin users...
  34. ncbi Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy
    Giovanni Corrao
    Department of Statistics, Unit of Biostatistics and Epidemiology, University of Milano Bicocca, Milan, Italy
    Clin Ther 32:300-10. 2010
    ..However, inadequate adherence may reduce statins' protective effects...
  35. ncbi 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages
    Angela Pirillo
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Biochim Biophys Acta 1761:292-300. 2006
    ..These results suggest that 15-lipoxygenase might induce structural alterations of HDL3 particles that impair their capability of triggering reverse cholesterol transport...
  36. ncbi 5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis
    Gherardo Buccianti
    Department of Internal Medicine, Nephrology and Dialysis Unit, Bassini Hospital, Cinisello Balsamo, Milan, Italy
    Nephrol Dial Transplant 17:857-64. 2002
    ..Furthermore, homocysteine induces endothelial dysfunction by an increased inactivation of nitric oxide...
  37. ncbi HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling
    G D Norata
    Department of Pharmacological Sciences, University of Milan, Italy
    Arterioscler Thromb Vasc Biol 24:871-7. 2004
    ..The understanding of these mechanisms may provide new insights into the antiatherogenic role of HDL...
  38. ncbi Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency
    G Tibolla
    Department of Pharmacological Sciences, Universita degli Studi di Milano, 20133 Milan, Italy
    Atherosclerosis 210:78-87. 2010
    ..Aim of this study was to investigate aortic atherosclerosis development in a mouse model with central nervous system (CNS) restricted beta-amyloid precursor protein (APP) overexpression...
  39. ncbi Statins and oxidative stress during atherogenesis
    Giuseppe D Norata
    Department of Pharmacological Sciences, University of Milan, and Centro per lo Studio e la Prevenzione delle Vasculopatie Periferiche, Ospedale Bassini, Italy
    J Cardiovasc Risk 10:181-9. 2003
    ..Among their properties statins also possess antioxidant activities and the aim of this paper is to review the scientific evidence for such an effect and its possible clinical relevance...
  40. ncbi Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS
    G D Norata
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    J Intern Med 258:21-7. 2005
    ..We have investigated whether the presence of the D299G polymorphism and the co-segregated T399I polymorphism affects the intima-media thickness (IMT) in the general population...
  41. ncbi [Achievement of the therapeutic goals for dyslipidemia in clinical practice: results of a survey among general practice physicians from Lombardy]
    Elena Tragni
    Servizio di Epidemiologia e Farmacologia Preventiva SEFAP, Dipartimento di Scienze Farmacologiche, Universita degli Studi, Via Balzaretti, 9 20133 Milano
    Ital Heart J 4:47S-57S. 2003
    ....
  42. ncbi Effects of HDL3 on the expression of matrix-degrading proteases in human endothelial cells
    Giuseppe D Norata
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Int J Mol Med 12:73-8. 2003
    ..The expression pattern was confirmed by quantitative real-time PCR. In summary, a large repertoire of matrix-degrading proteases is expressed in endothelial cells, an expression that can be modulated by native and oxidized HDL3...
  43. ncbi Effects of fractalkine receptor variants on common carotid artery intima-media thickness
    Giuseppe D Norata
    Department of Pharmacological Sciences, University of Milan, Italy
    Stroke 37:1558-61. 2006
    ..In the present study, we investigated the possible association between CX3CR1variants and intima-media thickness (IMT)...
  44. ncbi Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: a pilot study
    I Baragetti
    Department of Medicine, Division of Nephrology and Dialysis, Cinisello Balsamo, University of Milan, Milan, Italy
    Blood Purif 24:369-76. 2006
    ..Advanced glycation end products (AGEs) are markers of oxidative stress...
  45. ncbi Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL
    G D Norata
    Department of Pharmacological Sciences, University of Milano, Italy
    Nutr Metab Cardiovasc Dis 12:297-305. 2002
    ....
  46. ncbi Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells
    G D Norata
    Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy
    Int J Mol Med 16:717-22. 2005
    ..Modulation of gene expression in the endothelium should be taken into account when studying the effects of LXR and RXR agonists on lipid metabolism in the arterial wall...
  47. ncbi Overexpression of inducible heat shock protein 70 in Cos-1 cells fails to protect from cytotoxicity of oxidized ldls
    A Pirillo
    Institute of Pharmacological Sciences, University of Milano, Italy
    Arterioscler Thromb Vasc Biol 21:348-54. 2001
    ..Thus, the Hsp70 response, although induced by OxLDLs, cannot protect cells from lipoprotein toxicity...
  48. ncbi Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: Molecular mechanisms and gene expression studies
    G D Norata
    Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy
    J Mol Cell Cardiol 40:484-94. 2006
    ..These results support the possible involvement of hypertriglyceridemic TGRLs in endothelial dysfunction via induction of a pro-inflammatory and pro-thrombotic state...
  49. ncbi The database of Italian general practitioners allows a reliable determination of the prevalence of myocardial infarction
    Alessandro Filippi
    Italian College of General Practitioners, Florence, Italy
    Ital Heart J 6:311-4. 2005
    ..CONCLUSIONS: The prevalence of MI diagnosis in the HSD is very close to that obtained by other epidemiological methods. Querying the database can provide a simple and inexpensive way to estimate and monitor the prevalence of MI in Italy...
  50. ncbi Novel statins: pharmacological and clinical results
    Chiara Bolego
    Nutrition Foundation of Italy, Via S Pietro all'Orto 17, 20121 Milan, Italy
    Cardiovasc Drugs Ther 16:251-7. 2002
    ....
  51. ncbi Cholesterol control in stroke prevention in Italy: a cross-sectional study in family practice
    Alessandro Filippi
    Italian College of General Practitioners, Florence, Italy
    Eur J Cardiovasc Prev Rehabil 12:159-63. 2005
    ..However a relatively large number of patients (646) with high plasma lipids remained untreated. CONCLUSIONS: Monitoring and intervention strategies on plasma lipid levels in patients with a diagnosis of stroke or TIA need to be improved...
  52. ncbi Secondary prevention of myocardial infarction: a survey in primary care
    Alessandro Filippi
    Italian College of General Practitioners, Florence, Italy
    J Cardiovasc Med (Hagerstown) 7:422-6. 2006
    ..Clearly, secondary prevention requires major improvement...
  53. ncbi Triglyceride-rich lipoproteins from normotrygliceridemic subjects and hyperlipidemic patients differently affect endothelial cell activation and gene expression patterns
    Giuseppe D Norata
    Circ Res 100:e81. 2007
  54. ncbi Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery
    Giuseppe Danilo Norata
    Stroke 38:2844-6. 2007
    ..52) (P<0.01). CONCLUSIONS: We show here that the L:A ratio is a powerful independent predictor of IMT in healthy subjects and correlates with several anthropometric, metabolic, and clinical parameters better than each single adipokine...